Market Forecast By Product Type (Monovalent, Combinational, Divalent, Trivalent, Others), By End Users (Hospitals, Healthcare Centers, Others) And Competitive Landscape
Product Code: ETC332192 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 4 | |
Report Name | Bangladesh Measles, Mumps and Rubella Vaccines Market |
Forecast period | 2025-2031 |
CAGR | 6.8% |
Growing Sector | Healthcare |
Bangladesh Measles, Mumps and Rubella Vaccines Market report thoroughly covers the market by product type and by end users. The market report provides an unbiased and detailed analysis of the ongoing market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
Bangladesh Measles, Mumps and Rubella Vaccines Market has shown significant growth, driven by public health campaigns and government initiatives aimed at achieving high immunization coverage among children. With the support of international health organizations and the implementation of the Expanded Programme on Immunization (EPI), Bangladesh has made considerable strides in controlling these infectious diseases. Recent efforts to enhance vaccine accessibility and affordability, coupled with increasing public awareness about the importance of vaccinations, are expected to further propel the market's expansion. However, challenges such as vaccine hesitancy, logistical issues in rural and hard-to-reach areas, and the need for continuous healthcare worker training remain critical areas for ongoing focus.
According to 6Wresearch, the Bangladesh Measles, Mumps and Rubella Vaccines Market size is expected to grow at a significant CAGR of 6.8% during the forecast period 2025-2031. The expansion of the Bangladesh measles, mumps, and rubella (MMR) vaccines market is significantly driven by several factors. Foremost among these is the government's commitment to public health, demonstrated through the implementation of the Expanded Programme on Immunization (EPI) and collaboration with international health organizations. This partnership has been pivotal in reducing incidences of these infectious diseases through mass immunization campaigns, which have also served to educate the public about the critical importance of vaccinations. Additionally, efforts have been made to increase the affordability and accessibility of vaccines, particularly in underserved areas, thereby ensuring a wider reach. The influence of these drivers is further amplified by advances in vaccine technology and distribution methods, making it possible to store and transport vaccines more effectively, even in challenging conditions. Public awareness campaigns have also played a crucial role, reduced misinformation and increasing understanding and acceptance of vaccinations among the population. These drivers have led to major rise in Bangladesh Measles, Mumps and Rubella Vaccines Market Growth.
However, the path to achieving widespread vaccine coverage is beset with challenges. Vaccine hesitancy remains a significant hurdle, fueled by misinformation, cultural beliefs, and skepticism towards pharmaceutical interventions. This issue is particularly pronounced in rural and hard-to-reach areas, where access to accurate health information can be limited. Logistical problems also pose a substantial challenge, as ensuring the consistent delivery and storage of vaccines in remote areas requires robust infrastructure and planning. There is also a critical need for ongoing training for healthcare workers, who are on the frontline of this effort. Keeping them informed about the latest vaccination techniques, handling procedures, and public health information is essential for the program’s success. Addressing these challenges requires a multifaceted approach, combining public education, infrastructure development, and continuous support and training for healthcare professionals.
Although there are several market players available in the Bangladesh Measles, Mumps and Rubella Vaccines Market, however few of them are having the most of market share. These companies are Gavi the Vaccine Alliance, World Health Organization, UNICEF, Serum Institute of India, GlaxoSmithKline, Merck & Co, Bangladesh Ministry of Health and Family Welfare, Beximco Pharmaceuticals Ltd, etc.
Measles, Mumps and Rubella Vaccines Market in Bangladesh is growing and government’s regulation and initiatives are helping in the extension of the market. The government has launched national immunization days, focusing on administering MMR vaccines to children across all regions, particularly targeting those in remote and hard-to-reach areas. Partnerships with local NGOs and international bodies such as Gavi, WHO, and UNICEF have been instrumental in increasing these efforts, providing both financial and logistical support. To tackle vaccine hesitancy, the government has also invested in large public awareness campaigns, utilizing a variety of media platforms to educate the population about the benefits of vaccinations.
Bangladesh Measles, Mumps and Rubella Vaccines Industry is anticipated to grow in future attributed to technological advancements in vaccine production and storage are expected to significantly improve vaccine stability and shelf-life, reducing the risks associated with cold chain logistics. Apart from this, the adoption of digital health initiatives, such as electronic immunization registries, will enable better tracking of vaccination coverage and facilitate more targeted immunization campaigns.
According to Dhaval, Research Manager, 6Wresearch, Combinational Vaccines segment is expected to grow more in future attributed to the combination vaccine's efficiency in protecting against all three diseases in a single administration. This not only simplifies the immunization process but also increases the likelihood of higher coverage rates across different population demographics.
Healthcare Centers are expected to grow more in future attributed to a strategic emphasis on decentralizing healthcare services to ensure broader and more equitable access to essential medical interventions, including vaccinations.
The report offers a comprehensive study of the subsequent market segments:
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bangladesh Measles, Mumps And Rubella Vaccines Market Overview |
3.1 Bangladesh Country Macro Economic Indicators |
3.2 Bangladesh Measles, Mumps And Rubella Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Bangladesh Measles, Mumps And Rubella Vaccines Market - Industry Life Cycle |
3.4 Bangladesh Measles, Mumps And Rubella Vaccines Market - Porter's Five Forces |
3.5 Bangladesh Measles, Mumps And Rubella Vaccines Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Bangladesh Measles, Mumps And Rubella Vaccines Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Bangladesh Measles, Mumps And Rubella Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Government initiatives to increase vaccination coverage |
4.2.2 Growing awareness among the population about the importance of vaccination |
4.2.3 Increase in healthcare expenditure in Bangladesh |
4.3 Market Restraints |
4.3.1 Lack of proper healthcare infrastructure in remote areas |
4.3.2 Vaccine hesitancy among certain segments of the population |
4.3.3 Limited access to vaccines in rural areas |
5 Bangladesh Measles, Mumps And Rubella Vaccines Market Trends |
6 Bangladesh Measles, Mumps And Rubella Vaccines Market, By Types |
6.1 Bangladesh Measles, Mumps And Rubella Vaccines Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Bangladesh Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Bangladesh Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Monovalent, 2021 - 2031F |
6.1.4 Bangladesh Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Combinational, 2021 - 2031F |
6.1.5 Bangladesh Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Divalent, 2021 - 2031F |
6.1.6 Bangladesh Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Trivalent, 2021 - 2031F |
6.1.7 Bangladesh Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Bangladesh Measles, Mumps And Rubella Vaccines Market, By End Users |
6.2.1 Overview and Analysis |
6.2.2 Bangladesh Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.2.3 Bangladesh Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Healthcare Centers, 2021 - 2031F |
6.2.4 Bangladesh Measles, Mumps And Rubella Vaccines Market Revenues & Volume, By Others, 2021 - 2031F |
7 Bangladesh Measles, Mumps And Rubella Vaccines Market Import-Export Trade Statistics |
7.1 Bangladesh Measles, Mumps And Rubella Vaccines Market Export to Major Countries |
7.2 Bangladesh Measles, Mumps And Rubella Vaccines Market Imports from Major Countries |
8 Bangladesh Measles, Mumps And Rubella Vaccines Market Key Performance Indicators |
8.1 Immunization coverage rates in target age groups |
8.2 Number of vaccination campaigns conducted annually |
8.3 Percentage of healthcare facilities equipped to store and administer vaccines |
9 Bangladesh Measles, Mumps And Rubella Vaccines Market - Opportunity Assessment |
9.1 Bangladesh Measles, Mumps And Rubella Vaccines Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Bangladesh Measles, Mumps And Rubella Vaccines Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 Bangladesh Measles, Mumps And Rubella Vaccines Market - Competitive Landscape |
10.1 Bangladesh Measles, Mumps And Rubella Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Bangladesh Measles, Mumps And Rubella Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |